Enter Wall Street with Street Insider PremiumRequest your 1 week free trial here.
Cure Pharmaceuticals (OTCQB: CURR) is a broad platform technology company that develops proprietary pharmaceuticals, nutraceuticals and topical delivery systems, currently holding 15 patents. This technology offers a number of unique immediate and controlled release drug delivery vehicles designed to improve efficacy, safety and patient experience for a wide range of active ingredients. As a technology-oriented company with a broad patent portfolio, we continue to develop innovative technologies for the future that are part of our incubator strategy to monetize our intellectual property.
The Sera Labs, Inc. (“Sera Labs”), a wholly owned subsidiary of CURE, specializes in wellness and beauty with cutting-edge technology and high-quality products using proprietary, science-backed formulas. is a trusted leader in More than 25 products are marketed under the Seratopical(TM), Seratopical Revolution(TM), SeraLabs(TM) and Nutri-Strips(TM) brand names. The company sells its products at affordable prices, makes them easily accessible on a global scale, and is strategically positioned to grow its beauty and health products into an at-home brand. It is sold directly to consumers with subscription and save options, as well as at major pharmaceutical and grocery chains and mass retailers nationwide. For more information, please visit the company’s websites at www.Seratopicalrevolution.com, www.Seratopical.com, and www.Seralabshealth.com. Follow Sera Labs on Instagram, Twitter, and Facebook at @seratopical.
To view IBN’s virtual coverage of the 148th Annual National Investment Bankers Association (“NIBA”) Conference, please visit https://ibn.fm/NIBA2022.
About InvestorBrandNetwork virtual coverage
InvestorBrandNetwork (“IBN”), a multifaceted financial news and publishing company, provides the online investment community with a bespoke portal containing profiles of each company participating in NIBA’s 148th Annual Investment Conference. IBN uses social media and syndicated articles to maximize event visibility, as well as enabling expert assessment of each company through one-click access to market research tools and helpful website links. increase.
For more than a decade, IBN has provided real-time coverage of hundreds of global events and conferences through its various brands, social media accounts and investment newsletters. To further increase the visibility of companies participating in these events and ensure the success of event collaborations this year, IBN’s syndication partners are committed to helping millions of investors access financial websites and platforms every day. We have expanded our digital coverage to include individual broadcasts on
For more information, please visit https://www.InvestorBrandNetwork.com.
If published or republished, please see full terms of use and disclaimer on InvestorBrandNetwork website applicable to all content provided by IBN: http://IBN.fm/Disclaimer
Investor Brand Network (IBN)
Los Angeles, California
www.InvestorBrandNetwork.com
310.299.1717 office
[email protected]
